NEAR is betting that AI agents will transact on-chain at machine speed and need a blockchain built for them. The thesis, the June upgrade, and the catch.
Source: https://crypto.news/near-ai-agents-settlement-layer/
NEAR is betting that AI agents will transact on-chain at machine speed and need a blockchain built for them. The thesis, the June upgrade, and the catch.
Source: https://crypto.news/near-ai-agents-settlement-layer/
In times when investors are pulling funds out of the spot exchange-traded funds tracking ETH and especially BTC, their behavior toward XRP, HYPE, and SOL has been entirely contrasting. The ETFs following the three altcoins’ performances continue to see more net inflows even as the market stagnates and uncertainty builds. XRP, SOL, HYPE ETFs Keep…
AI-driven drug discovery’s rapid progression to human trials could revolutionize biotech timelines, potentially accelerating medical advancements. The post Absci Corporation progresses ABS-201 into human trials, bolstering AI-driven drug discovery appeared first on Crypto Briefing.
In BlackRock Bitcoin news today, three-quarters of investors in BlackRock’s iShares Bitcoin Trust ETF had never owned an ETF before buying it, and once inside, many began buying S&P 500 funds, gold ETFs, and AI products from the same issuer. The narrative was always that Wall Street money would flow into crypto through these wrappers.…